Examination of bile acid negative feedback regulation in rats
Autor: | Roger A. Davis, Carlo A. Musso, Michael Straka, Gerri R. Lattier, Jane Archambault-Schexnayder, Monica Malone-McNeal, Paul M. Hyde |
---|---|
Jazyk: | angličtina |
Rok vydání: | 1988 |
Předmět: |
medicine.medical_specialty
Bile acid Cholesterol medicine.drug_class Cell Biology QD415-436 Biology Reductase Taurocholic acid digestive system Biochemistry chemistry.chemical_compound Endocrinology medicine.anatomical_structure chemistry In vivo Internal medicine Duodenum medicine Secretion Lovastatin medicine.drug |
Zdroj: | Journal of Lipid Research, Vol 29, Iss 2, Pp 202-211 (1988) |
ISSN: | 0022-2275 |
Popis: | Recent data obtained using cultured rat hepatocytes showed that bile acids do not inhibit bile acid synthesis, whereas cholesterol concentrations vary in parallel with bile acid synthesis (Davis et al. (1983. J. Biol. Chem. 258: 4079-4082). This led us to re-evaluate in vivo experiments upon which the consensus that bile acid synthesis is primarily regulated by bile acid ''negative feedback'' is based. Infusion of taurocholate into either the jugular vein or duodenum of bile-diverted rats stimulated biliary cholesterol secretion and bile flow, but it did not inhibit bile acid synthesis. The lack of an inhibitory effect was evident using several different infusion rates of taurocholate. Even at the greatest rate of taurocholate infusion (25 mumol/(100 g.hr] there was no significant inhibition of bile acid synthesis. In contrast, infusing mevinolin (1 mg/hr), a potent competitive inhibitor of HMG-CoA reductase, almost completely inhibited bile acid synthesis and biliary cholesterol secretion. Since mevinolin did not affect bile flow, these results cannot be ascribed to bile secretory failure. Thus, while these studies suggest that taurocholate may not regulate bile acid synthesis directly via negative feedback, cholesterol is likely to act as a positive effector of bile acid synthesis. |
Databáze: | OpenAIRE |
Externí odkaz: |